CAS: 1309784-09-5
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | ITK inhibitor 2 REF: IN-DA01V4L4CAS: 1309784-09-5 | 99.66% | A consultar | Seg 02 Dez 24 |
 | (αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide REF: 3D-JCC78409CAS: 1309784-09-5 | Min. 95% | A consultar | Seg 13 Jan 25 |
 | ITK inhibitor 2 REF: TM-T11690CAS: 1309784-09-5 | - - - | 53,00 €~1.105,00 € | Seg 03 Mar 25 |
Ref: IN-DA01V4L4
| 5mg | 604,00 € | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 2 de Dezembro de 2024
![(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholi…](https://static.cymitquimica.com/products/3D/thumb/JCC78409.jpg)
(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide
CAS:1309784-09-5
(αS)-N,α-Dimethyl-N-[2-(4,5,6,7-tetrahydro-6,6-dimethyl-1H-indazol-3-yl)-1H-indol-6-yl]-4-morpholineacetamide (PDE10A) is a potential drug target for various inflammatory diseases such as reactive arthritis …
Fórmula:
C25H33N5O2
Pureza:
Min. 95%
Peso molecular:
435.6 g/mol
Ref: 3D-JCC78409
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 13 de Janeiro de 2025
ITK inhibitor 2
CAS:1309784-09-5
ITK inhibitor 2 is a interleukin-2-inducible T-cell kinase (ITK) inhibitor , with an IC50 of …
Fórmula:
C25H33N5O2
Cor e Forma:
Solid
Peso molecular:
435.56
Ref: TM-T11690
| 50mg | 738,00 € | ||
| 100mg | 1.105,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 3 de Março de 2025
